Xevinapant Completed Phase N/A Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02022098
Debio 1143-201 Dose-finding and Efficacy Phase I/II Trial